COVID-19: Pháp chuẩn bị thử nghiệm lâm sàng 3 loại thuốc điều trị
Ngày 11/3, Bộ Nghiên cứu Pháp cho biết nước này sẽ bắt đầu chiến dịch thử nghiệm lâm sàng 3 loại thuốc trị bệnh COVID-19 mang tên Discovery vào cuối tuần này hoặc đầu tuần sau. Tổng cộng sẽ có 800 bệnh nhân Pháp bị nhiễm virus SARS-CoV-2 tham gia chương trình thử nghiệm này. Họ được chia thành 4 nhóm.
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
(TTXVN/Vietnam+)